Skip to main content

Table 1 Cancer cohort: characteristics and number of mtDNA mutations identified

From: Performance of mitochondrial DNA mutations detecting early stage cancer

Sample

Age

Diagnosis

Stage

Blood/Tumor

Blood/Body Fluid*

Lung 1

54

SCC

IA

6

1

Lung 2

51

Adenocarcinoma

IA

3

n/a

Lung 3

72

Adenocarcinoma

IA

2 (D-Loop)

0

Lung 4

70

BALV CA

IA

2

0

Lung 5

77

SCC

IA

3

0

Lung 6

61

Adenocarcinoma

IIA

0

1

Lung 7

73

NSCLC

IIB

0

0

Lung 9

64

Carcinoid Tumor

IA

1

1

Bladder 1

86

TCC

I

1

n/a

Bladder 2

53

SCC

I

1

0

Bladder 3

62

Large Cell Undifferentiated CA

I

1

0

Bladder 4

72

TCC

II

n/a

4

Kidney 1

74

Renal Cell CA

II

3

0

Kidney 2

58

Renal Cell CA

II/IV

2

n/a

Kidney 3

65

Renal Cell CA

III

1

0

Kidney 4

72

Renal Cell CA

III

2

0

Kidney 5

66

Renal Cell CA

II

1

n/a

Kidney 6

52

Renal Cell CA

II/III

2

1

Kidney 7

33

Renal Cell CA

I

n/a

0

Kidney 8

61

Renal Cell CA

II

0

1

Kidney 9

75

Renal Cell CA

II

1

0

Kidney 10

62

Renal Cell CA

I

0

1

Kidney 11

21

Renal Cell CA

II

0

0

Kidney 12

44

Renal Cell CA

I

0

1

Kidney 13

59

Renal Cell CA

II

1

0

Kidney 14

59

Renal Cell CA

I

1 (D-Loop)

0

  1. * all lung body fluids were pre-amplified by WGA